The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKings Arms Yard Regulatory News (KAY)

Share Price Information for Kings Arms Yard (KAY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.40
Bid: 18.90
Ask: 19.90
Change: 0.00 (0.00%)
Spread: 1.00 (5.291%)
Open: 19.40
High: 19.40
Low: 19.40
Prev. Close: 19.40
KAY Live PriceLast checked at -
Kings Arms Yard VCT is an Investment Trust

To produce a regular and predictable dividend stream with an appreciation in capital value, invests in a broad portfolio of higher growth businesses across a variety of sectors of the UK economy including higher risk technology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

21 May 2019 15:51



AGM Statement

Kings Arms Yard VCT PLC

LEI Code 213800DK8H27QY3J5R45

At an Annual General Meeting of Kings Arms Yard VCT PLC, duly convened and held at the City of London Club, 19 Old Broad Street, London on 21 May 2019 the following resolutions were passed:Ordinary resolutions numbers 1 to 7 were passed.

The following items of Special Business were passed of which resolution 8 was passed as ordinary resolution and 9 to 11 were passed as special resolutions.

Special Business8. Authority to allot sharesThe Directors be generally and unconditionally authorised in accordance with section 551 of the Companies Act 2006 (the “Act”) to allot Ordinary shares of nominal value 1 penny per share in the Company up to a maximum aggregate nominal amount of £703,712 (representing approximately 20% of the issued share capital as at the date of this notice) provided that this authority shall expire 15 months from the date that this resolution is passed, or, if earlier, the conclusion of the next Annual General Meeting of the Company, but so that the Company may, before the expiry, make an offer or agreement which would or might require shares to be allotted or rights to subscribe for or convert securities into shares to be granted after such expiry and the Directors may allot shares or grant rights to subscribe for or convert securities into shares pursuant to such an offer or agreement as if the authority had not expired.

9. Authority for the disapplication of pre-emption rightsThat the Directors be empowered, pursuant to sections 570 and 573 of the Act, to allot equity securities (within the meaning of section 560 of the Act) for cash pursuant to the authority conferred by resolution number 8 and/or sell ordinary shares held by the Company as treasury shares for cash as if section 561(1) of the Act did not apply to any such allotment or sale.

Under this power the Directors may impose any limits or restrictions and make any arrangements which they deem necessary or expedient to deal with any treasury shares, fractional entitlements, record dates, legal, regulatory or practical problems in, or laws of, any territory or other matter, arising under the laws of, or the requirements of any recognised regulatory body or any stock exchange in, any territory or any other matter.

This power shall expire 15 months from the date that this resolution is passed or, if earlier, the conclusion of the next Annual General Meeting of the Company, save that the Company may, before such expiry, make an offer or agreement which would or might require equity securities to be allotted after such expiry and the Directors may allot equity securities in pursuance of any such offer or agreement as if this power had not expired.

10. Authority to purchase own sharesThat, subject to and in accordance with the Company’s Articles of Association, the Company be generally and unconditionally authorised, pursuant to and in accordance with section 701 of the Act, to make market purchases (within the meaning of Section 693(4) of the Act) of Ordinary shares of 1 penny each in the capital of the Company (“Ordinary shares”), on such terms as the Directors think fit, provided always that:

(a) the maximum aggregate number of Ordinary shares hereby authorised to be purchased is 52,743,180 shares or, if lower, such number of Ordinary shares as shall equal 14.99% of the issued Ordinary share capital of the Company as at the date of the passing of this resolution (excluding any Ordinary shares held in treasury);

(b) the minimum price, exclusive of any expenses, which may be paid for an Ordinary share is 1 penny;

(c) the maximum price, exclusive of any expenses, which may be paid for a share shall be an amount equal to the higher of (a) 105% of the average of the middle market quotations for the share, as derived from the London Stock Exchange Daily Official List, for the five business days immediately preceding the date on which the share is purchased; and (b) the amount stipulated by Article 5(1) of the Buy-back and Stabilisation Regulation 2003;

(d) the authority hereby conferred shall, unless previously revoked, varied or renewed, expire 15 months from the date that this resolution is passed or, if earlier, at the conclusion of the next Annual General Meeting; and

(e) the Company may enter into a contract or contracts to purchase shares under this authority before the expiry of the authority which will or may be executed wholly or partly after the expiry of the authority, and may make a purchase of shares in pursuance of any such contract or contracts as if the authority conferred hereby had not expired.

11. Authority to sell treasury sharesThat the Directors be empowered to sell treasury shares at the higher of the prevailing current share price and the price bought in at.

21 May 2019

For further information please contact: Albion Capital Group LLP Tel: 0207 601 1850


Date   Source Headline
24th Apr 20241:45 pmGNWPortfolio Company Update
19th Apr 20244:29 pmGNWKings Arms Yard VCT PLC: Annual Financial Report
16th Apr 20242:25 pmGNWIssue of Equity and Total Voting Rights
3rd Apr 20242:06 pmGNWDividend Declaration
28th Mar 20242:00 pmGNWTotal voting rights and Capital
25th Mar 20242:30 pmGNWDirector/PDMR Shareholding
25th Mar 202410:15 amGNWIssue of Equity and Total Voting Rights
19th Mar 20249:32 amGNWCLOSURE OF THE COMPANY'S OFFER
12th Mar 20243:30 pmGNWNAV announcement and Portfolio company update
29th Feb 20242:00 pmGNWTotal voting rights and Capital
31st Jan 20241:30 pmGNWTotal voting rights and Capital
29th Dec 20231:00 pmGNWTotal voting rights and Capital
19th Dec 20235:37 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
15th Dec 20233:45 pmGNWPublication of Prospectus
5th Dec 202312:49 pmGNWKings Arms Yard VCT PLC: Interim Management Statement
30th Nov 20232:00 pmGNWTotal voting rights and Capital
1st Nov 20239:41 amGNWDirector/PDMR Shareholding
31st Oct 20239:48 amGNWIssue of Equity and Total Voting Rights and Capital
30th Oct 20232:00 pmGNWChange of the Company's Auditor
19th Oct 20232:54 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
12th Oct 202310:30 amGNWStatement regarding the proposed issue of a prospectus
29th Sep 20232:29 pmGNWTotal voting rights and Capital
22nd Sep 202312:50 pmGNWKings Arms Yard VCT PLC: Half-yearly Financial Report
1st Sep 202311:15 amGNWDirectorate change
31st Aug 20232:00 pmGNWTotal voting rights and Capital
31st Jul 20232:14 pmGNWTotal voting rights and Capital
30th Jun 20232:10 pmGNWTotal voting rights and Capital
29th Jun 20231:50 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
7th Jun 20236:52 pmGNWAGM Statement
7th Jun 202311:41 amGNWKings Arms Yard VCT PLC: Interim Management Statement
31st May 20232:00 pmGNWTotal voting rights and Capital
28th Apr 202310:23 amGNWDirector/PDMR Shareholding
28th Apr 202310:22 amGNWIssue of Equity and Total Voting Rights and Capital
19th Apr 20235:30 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
19th Apr 20239:03 amGNWDirectorate Notification
14th Apr 20232:30 pmGNWIssue of Equity and Total Voting Rights and Capital
11th Apr 20234:45 pmGNWPublication of a supplementary prospectus
5th Apr 20236:04 pmGNWKings Arms Yard VCT PLC: Annual Financial Report
31st Mar 20232:30 pmGNWIssue of Equity and Total Voting Rights and Capital
29th Mar 20231:19 pmGNWDividend Declaration
16th Mar 20239:09 amGNWClosure of the Company's offer
28th Feb 20232:00 pmGNWTotal voting rights and Capital
24th Feb 20236:26 pmGNWChange of Allotment Date
23rd Feb 202312:45 pmGNWNAV Announcement
31st Jan 20232:00 pmGNWTotal voting rights and Capital
18th Jan 20233:49 pmGNWOffer Update
30th Dec 202212:00 pmGNWTotal voting rights and Capital
19th Dec 20226:06 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
5th Dec 20223:45 pmGNWDirector/PDMR Shareholding
5th Dec 202212:15 pmGNWIssue of Equity and Total Voting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.